Browsing Over 414 Presentations

Sort By
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36) Industry Satellite Symposium

Evolution of HER2-targeted therapies: The role of antibody drug conjugates (ID 829)

Lecture Time
13:20 - 13:35
Speakers
  • Fabrice André (Villejuif, France)
Session Name
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
13:00 - 14:00
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36) Industry Satellite Symposium

The emerging treatment paradigm for HER driven breast cancer (ID 830)

Lecture Time
13:35 - 13:50
Speakers
  • Javier Cortes (Barcelona, Spain)
Session Name
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
13:00 - 14:00
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36) Industry Satellite Symposium

Q&A with speaker panel (ID 831)

Lecture Time
13:50 - 14:00
Speakers
  • Fabrice André (Villejuif, France)
  • Javier Cortes (Barcelona, Spain)
  • Hope S. Rugo (San Francisco, CA, United States of America)
Session Name
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
13:00 - 14:00
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36) Industry Satellite Symposium

Welcome & introduction (ID 827)

Lecture Time
13:00 - 13:05
Speakers
  • Fabrice André (Villejuif, France)
Session Name
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
13:00 - 14:00
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36) Industry Satellite Symposium

Current progress in HER2 positive metastatic breast cancer (ID 828)

Lecture Time
13:05 - 13:20
Speakers
  • Hope S. Rugo (San Francisco, CA, United States of America)
Session Name
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
13:00 - 14:00
Early breast cancer: HER2 positive (ID 4) Educational session

Neoadjuvant therapy in ER+ positive disease (ID 2)

Lecture Time
14:30 - 14:50
Speakers
  • Jens Huober (Ulm, Germany)
Session Name
Early breast cancer: HER2 positive (ID 4)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
14:30 - 16:00
Early breast cancer: HER2 positive (ID 4) Educational session

Adjuvant therapy (ID 3)

Lecture Time
14:50 - 15:10
Speakers
  • Edith A. Perez (Jacksonville, United States of America)
Session Name
Early breast cancer: HER2 positive (ID 4)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
14:30 - 16:00
Early breast cancer: HER2 positive (ID 4) Educational session

Neoadjuvant therapy in ER-negative disease (ID 4)

Lecture Time
15:10 - 15:30
Speakers
  • Aleix Prat (Barcelona, Spain)
Session Name
Early breast cancer: HER2 positive (ID 4)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
14:30 - 16:00
Early breast cancer: HER2 positive (ID 4) Educational session

Extended adjuvant therapy (ID 5)

Lecture Time
15:30 - 15:50
Speakers
  • Miguel Martín (Madrid, Spain)
Session Name
Early breast cancer: HER2 positive (ID 4)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
14:30 - 16:00
Early breast cancer: HER2 positive (ID 4) Educational session

Q&A (ID 6)

Lecture Time
15:50 - 16:00
Session Name
Early breast cancer: HER2 positive (ID 4)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
14:30 - 16:00
Early breast cancer: HER2-/HR positive (ID 6) Educational session

Neoadjuvant endocrine therapy, when and why? (ID 12)

Lecture Time
16:30 - 16:50
Speakers
  • Cynthia X. Ma (St. Louis, MO, United States of America)
Session Name
Early breast cancer: HER2-/HR positive (ID 6)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
16:30 - 18:00
Early breast cancer: HER2-/HR positive (ID 6) Educational session

Genomics of intrinsic endocrine resistance, new insights and therapeutic hypotheses (ID 13)

Lecture Time
16:50 - 17:10
Speakers
  • Charles M. Perou (Chapel Hill, NC, United States of America)
Session Name
Early breast cancer: HER2-/HR positive (ID 6)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
16:30 - 18:00